The Reduction Of Polio Virus Initiative By Official With Several Collaborations And Partnerships To Boost The Polio Vaccine Market Growth
Polio Vaccine Market |
Polio Vaccine Market By
Vaccine Type (Oral Vaccine, Inactivated Vaccine, Others), By Application (Private,
Public) and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022
– 2030
The
global Polio Vaccine Market is estimated to be valued at US$ 4.75 billion in
2023 and is expected to exhibit a CAGR of 5.24 % over the forecast period, as
highlighted in a new report published by Coherent Market Insights.
Market Overview:
Inactivated
Poliovirus Vaccine is the only polio
vaccine that is being inoculated to the patients U.S since 2000. PV saves one
from critical disorders led by poliovirus in around everyone who has been given
all the suggested dosages. Oral polio vaccine saves the individual from polio
paralysis by inhibiting the extent of PV to the nervous system.
Competitive Landscape:
Key
players involved in the growth of global Polio
Vaccine Market is
Sanofi Pasteur Limited, Serum Institute of India Pvt. Ltd., Astellas Pharma
Inc., Panacea Biotec Ltd., Abbvie Inc., Pfizer Inc., Merck & Co., Inc.,
Novartis AG, Bharat Biotech and others.
Market Key Drivers:
The
reduction of polio virus initiative by official with several collaborations and
partnerships is expected to augment the growth of global polio vaccine market.
For instance, as per the polioeradication.org, over 200 countries were included
with around 2.5 billion children being vaccinated & invested around US$ 4
billion across the globe.
The
rising population and the prevention of the population from other viruses is
projected to propel the growth of global polio vaccine market. For instance, as
per cbs.nl, 179.8 thousand of the child birth were reported in year 2021 across
the globe.
Covid-19 Impact Analysis:
COVID-19
pandemic has adversely affected the growth of global Polio Vaccine Market due to the disruption on the manufacturing of
vaccine. COVID-19 has also interrupted the polio vaccine plans globally. Stringent
rules and regulation for medical tourism with decrease of immunization campaign
due to shut down which led to the less necessity of the polio vaccine. Pandemic
has decreased the manufacture of the polio vaccine owing to lack of staff led to
interrupted supply chain. The worldwide shutdown for inhibiting spread of
corona virus has also impacted the production units of polio vaccine.
Key Takeaways:
The
global polio vaccine market is anticipated to exhibit a CAGR of 5.24 % during
the forecast period owing to the rising launch of injectable vaccines. For
instance, in January 22nd, 2018 India introduced its initial injectable polio
vaccine as an IPV.
Among
regions, North America, Europe and Asia Pacific are expected to witness robust
growth in global Polio Vaccine Market due
to rise in population, rising usage of polio vaccine, regulatory initiatives
and approvals and increasing approvals and launches. For instance, as per WHO,
over 110 million children below 5 years were vaccinated for polio in India on
January 31st, 2021.
Comments
Post a Comment